EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).
about
LL5beta directs the translocation of filamin A and SHIP2 to sites of phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) accumulation, and PtdIns(3,4,5)P3 localization is mutually modified by co-recruited SHIP2.The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cellsThe paradox role of caspase cascade in ionizing radiation therapyVandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport functionVersican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapyPathways to tamoxifen resistance.EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.EGFR associated expression profiles vary with breast tumor subtypeExosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer.The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networksGrowth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer.Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.IRS and TOR nutrient-signaling pathways act via juvenile hormone to influence honey bee caste fate.Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapyOptimal structural inference of signaling pathways from unordered and overlapping gene sets.Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway.Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locationsDifferent Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survivalNuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidenceDifferent Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or DocetaxelMiR-148a inhibits angiogenesis by targeting ERBB3.Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer.Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcomeMultiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arraysLack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancerTreatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experienceProteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways.Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.Disruption of actin filaments and suppression of pancreatic cancer cell viability and migration following treatment with polyisoprenylated cysteinyl amides.Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.Metastatic Renal Cancer: What Role for Everolimus?Radiation-induced signaling pathways that promote cancer cell survival (review).
P2860
Q24303607-D6C7D42C-3DD5-4D00-AD76-8B8039763D32Q24595836-9BDA4940-B75F-4970-8C0B-DB86DE72F69CQ28079723-1B0616D3-61BD-4B88-8B13-14786523DE6EQ28475378-93739F0C-B07F-43F2-8B55-173F6C8D3ACEQ28477876-E395F7B8-5EAD-404D-A868-9BBEB06CC2A6Q30441001-45EE952F-033E-413B-A6EF-4F9EBE7A63F4Q33258056-A77AB453-5A04-4EE9-9A52-1D94E2037482Q33292502-3FA2B628-E9A8-4123-9915-9B13AF8CA902Q33644570-B9EDBA47-735B-43CE-B8C7-BCAF6DA6DBE9Q34343043-8EA8A13A-6511-4D9C-AE38-AB265E10891FQ34433952-17AE9C33-AA0F-455F-B462-6C11A7E11832Q34908845-40686B17-80A3-42F1-8E7A-F9731523E139Q35071151-DD8E55AA-EDAB-4307-9162-70074270B0B1Q35094456-CF847198-9A75-47A0-8BF4-833D66DC49C6Q35539296-50A19F24-BB68-4B92-ADAC-E533C7FBA04FQ35606908-00D020ED-8D0B-4246-AA9E-8D577E18AE63Q35640228-53518DFF-8316-4C2F-A5F0-96DEB9AD473FQ35754761-832948B4-B86B-44E8-B8A9-A61C1C9A6DD2Q35807271-C783DF8F-AD72-47B6-B096-5514EC9ED47CQ35831012-C258F87F-AC89-4175-8C64-499F54176121Q35958353-C1018EA1-AB82-47B7-86C5-0FD268BA3D3EQ36225686-8A8F86D0-C586-448D-855D-75009D745BE6Q36250585-27B852AA-CF3C-4F33-BF49-C0A36E28DA50Q36652542-17496362-0547-4A7E-9AB4-DA9F8AAC9427Q36683208-90FEF184-62CD-4781-8851-8C8060F18975Q36973814-EEC870C9-6CEF-40F4-BA59-FE72E2104212Q37076592-0616B7AB-A023-48BA-80CA-9F9AA60BB71FQ37123533-6D116F17-0666-4FC6-ABA2-7C6B536E164BQ37160952-8606A8E5-FA5F-4860-B536-9AC533B02A92Q37356570-2C98C5F3-6D38-4CCD-8587-3600899E9311Q37362948-94493A11-C6E8-4AEE-A689-1457FF0A7142Q37368594-F1B1B093-2CB0-412D-8E79-4F8D97DA7A70Q37379205-C7D125B2-ACCC-4C5E-BA72-C9C3FD01F281Q37386163-D695CB37-1C2E-4612-9FC5-9EB049D6D570Q37390867-FF17A9BA-008A-4933-97A1-7E3280999152Q37447885-C7D70F1B-E6A0-408E-A835-F6466C65BEF1Q37467189-E921BE01-D0A3-41CD-8272-E7BA54B6F69BQ37709055-F4D9371A-8CEE-470E-9A3B-B5956479C4C8Q38207580-489E5340-C07E-4546-BE44-C5C2F1920E7EQ38244964-7F800810-460B-4256-AE33-7993B12DC0EB
P2860
EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
EGFR family signaling and its ...... ance to chemotherapy (Review).
@en
type
label
EGFR family signaling and its ...... ance to chemotherapy (Review).
@en
prefLabel
EGFR family signaling and its ...... ance to chemotherapy (Review).
@en
P2093
P1476
EGFR family signaling and its ...... ance to chemotherapy (Review).
@en
P2093
James A McCubrey
Linda S Steelman
Patrick M Navolanic
P304
P577
2003-02-01T00:00:00Z